agree @LeftYahoo if they are going to do another study in GVHD it needs to be an RCT. MAybe it's time to thaw out CHF LVAD etc and get that over the line rather than wasting more time on kids GVHD which is a tiny market anyway. The only reasons they pursued that was they thought it was the quickest way to a watershed approval that opens the door on off label sales accross the board.
agree @LeftYahoo if they are going to do another study in GVHD...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |